Tenosynovial giant cell tumour (pigmented villonodular synovitis-)-like changes in periprosthetic interface membranes

被引:1
|
作者
Soeder, Stephan [1 ]
Sesselmann, Stefan [2 ]
Aigner, Thomas [3 ]
Oehler, Stephan [4 ]
Agaimy, Abbas [1 ]
机构
[1] Univ Erlangen Nurnberg, Inst Pathol, D-91054 Erlangen, Germany
[2] Univ Erlangen Nurnberg, Dept Orthopaed Surg, D-91054 Erlangen, Germany
[3] Hosp Coburg, Inst Pathol, D-96450 Coburg, Germany
[4] Hosp Rummelsberg, Dept Orthopaed, D-90592 Schwarzenbruck, Germany
关键词
PVNS; PVNS-like; TSGCT; Tenosynovial giant cell tumour; Wear particles; Periprosthetic interface membranes; HISTOPATHOLOGICAL CONSENSUS CLASSIFICATION; INFLAMMATORY CYTOKINE; RHEUMATOID-ARTHRITIS; BONE-RESORPTION; WEAR PARTICLES; EXPRESSION; MACROPHAGES; KNEE; TRANSLOCATION; HYBRIDIZATION;
D O I
10.1007/s00428-015-1874-9
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Tenosynovial giant cell tumour (TSGCT; synonym, pigmented villonodular synovitis (PVNS)) is a rare low-grade mesenchymal neoplasm of either intra-articular or extra-articular origin. The etiopathogenesis of TSGCT is still uncertain, but recent studies showed a translocation involving colony-stimulating factor 1 (CSF-1) gene in a subset of cases. Histological features mimicking TSGCT can sometimes be encountered in periprosthetic interface membranes. To investigate the frequency and morphologic spectrum of this phenomenon, we conducted a systematic analysis of 477 periprosthetic interface membranes and performed immunohistochemical analysis on a subset of lesions compared to genuine TSGCT. In 26 of 477 periprosthetic membrane samples (5 %), at least some TSGCT-like features were found and 18 cases (4 %) strongly resembled it. Wear particles were detected in 100 % of the TSGCT-like lesions but only in 63.3 % of the whole cohort of periprosthetic membranes (p value < 0.001). Immunohistochemistry comparing true TSGCT and TSGCT-like membranes showed similar inflammatory infiltrates with slightly elevated CD3+/CD8+ T lymphocytes and a slightly higher proliferation index in TSGCT samples. In conclusion, TSGCT-like changes in periprosthetic membranes likely represent exuberant fibrohistiocytic inflammatory response induced by wear particles and should be distinguished from genuine (neoplastic) TSGCT. Although TSGCT and TSGCT-like periprosthetic membranes represent different entities, their comparable morphology might reflect analogous morphogenesis.
引用
收藏
页码:231 / 238
页数:8
相关论文
共 16 条
  • [1] Tenosynovial giant cell tumour (pigmented villonodular synovitis-)-like changes in periprosthetic interface membranes
    Stephan Söder
    Stefan Sesselmann
    Thomas Aigner
    Stephan Oehler
    Abbas Agaimy
    Virchows Archiv, 2016, 468 : 231 - 238
  • [2] Tenosynovial giant cell tumour/pigmented villonodular synovitis: Outcome of 294 patients before the era of kinase inhibitors
    Palmerini, Emanuela
    Staals, Eric L.
    Maki, Robert G.
    Pengo, Stefano
    Cioffi, Angela
    Gambarotti, Marco
    Picci, Piero
    Daolio, Primo Andrea
    Parafioriti, Antonina
    Morris, Carol
    Antonescu, Cristina R.
    Gronchi, Alessandro
    Casali, Paolo Giovanni
    Donati, Davide M.
    Ferrari, Stefano
    Stacchiotti, Silvia
    EUROPEAN JOURNAL OF CANCER, 2015, 51 (02) : 210 - 217
  • [3] Treatment of tenosynovial giant cell tumor and pigmented villonodular synovitis
    Ravi, Vinod
    Wang, Wei-Lien
    Lewis, Valerae O.
    CURRENT OPINION IN ONCOLOGY, 2011, 23 (04) : 361 - 366
  • [4] The management of diffuse-type giant cell tumour (pigmented villonodular synovitis) and giant cell tumour of tendon sheath (nodular tenosynovitis)
    van der Heijden, L.
    Gibbons, C. L. M. H.
    Dijkstra, P. D. S.
    Kroep, J. R.
    van Rijswijk, C. S. P.
    Nout, R. A.
    Bradley, K. M.
    Athanasou, N. A.
    Hogendoorn, P. C. W.
    van de Sande, M. A. J.
    JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 2012, 94B (07): : 882 - 888
  • [5] Diffuse pigmented villonodular synovitis (diffuse-type giant cell tumour) of the foot and ankle
    Stevenson, J. D.
    Jaiswal, A.
    Gregory, J. J.
    Mangham, D. C.
    Cribb, G.
    Cool, P.
    BONE & JOINT JOURNAL, 2013, 95B (03) : 384 - 390
  • [6] Pigmented villonodular synovitis/diffuse-type tenosynovial giant cell tumor: Opening options in management
    Eberst, L.
    Brahmi, M.
    Blay, J. -Y.
    Cassier, P. A.
    DRUGS OF THE FUTURE, 2017, 42 (02) : 105 - 111
  • [7] Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis
    Cassier, Philippe A.
    Gelderblom, Hans
    Stacchiotti, Silvia
    Thomas, David
    Maki, Robert G.
    Kroep, Judith R.
    van der Graaf, Winette T.
    Italiano, Antoine
    Seddon, Beatrice
    Domont, Julien
    Bompas, Emanuelle
    Wagner, Andrew J.
    Blay, Jean-Yves
    CANCER, 2012, 118 (06) : 1649 - 1655
  • [8] Tenosynovial Giant Cell Tumor, Diffuse Type/Pigmented Villonodular Synovitis in a Pars Defect A Case Report
    Kimura, Tetsuya
    Nishisho, Toshihiko
    Sakai, Toshinori
    Miyagi, Ryo
    Takao, Shoichiro
    Iwamoto, Seiji
    Higashino, Kosaku
    Takata, Yoichiro
    Goda, Yuichiro
    Toki, Shunichi
    Sairyo, Koichi
    SPINE, 2015, 40 (12) : E735 - E739
  • [9] Long-term outcome of the treatment of high-risk tenosynovial giant cell tumor/pigmented villonodular synovitis with radiotherapy and surgery
    Griffin, Anthony M.
    Ferguson, Peter C.
    Catton, Charles N.
    Chung, Peter W. M.
    White, Lawrence M.
    Wunder, Jay S.
    Bell, Robert S.
    O'Sullivan, Brian
    CANCER, 2012, 118 (19) : 4901 - 4909
  • [10] Localized and diffuse forms of tenosynovial giant cell tumor (formerly giant cell tumor of the tendon sheath and pigmented villonodular synovitis)
    Gouin, F.
    Noailles, T.
    ORTHOPAEDICS & TRAUMATOLOGY-SURGERY & RESEARCH, 2017, 103 (01) : S91 - S97